Inventor
BUNGARD CHRISTOPHER JAMES
US10 patents
⚠️ This page may combine multiple inventors who share the name “BUNGARD CHRISTOPHER JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
6 patentsUS11377438B2Jul 5, 2022
2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors
MERCK SHARP & DOHME6 citations83
US9278960B2Mar 8, 2016
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME4 citations82
US9663506B2May 30, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US9636337B2May 2, 2017
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME2 citations70
US10072003B2Sep 11, 2018
Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
MERCK SHARP & DOHME1 citations51
US11802122B2Oct 31, 2023
2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors
MERCK SHARP & DOHME0 citations50
MERCK SHARP & DOHME LLC
4 patentsUS12195445B2Jan 14, 2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors
MERCK SHARP & DOHME LLC0 citations60
US12344595B2Jul 1, 2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors
MERCK SHARP & DOHME LLC0 citations48
US12516046B2Jan 6, 2026
2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
MERCK SHARP & DOHME LLC0 citations46
US12565494B2Mar 3, 2026
Inhibitors of human respiratory syncytial virus and metapneumovirus
MERCK SHARP & DOHME LLC0 citations40